https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2022-03312
SNDX-5613 with Decitabine/Cedazuridine, and Venetoclax for the Treatment of Relapsed or Refractory...
SNDX-5613 with Decitabine/Cedazuridine, and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, SAVE Trial
https://www.healthdirect.gov.au/medicines/medicinal-product/aht,26810/decitabine-cedazuridine
Decitabine + cedazuridine | healthdirect
More information is available on Decitabine + cedazuridine including side effects, age restrictions, food interactions, whether the medicine is available at a...
decitabinehealthdirect
https://medlineplus.gov/druginfo/meds/a620050.html
Decitabine and Cedazuridine: MedlinePlus Drug Information
Decitabine and Cedazuridine: learn about side effects, dosage, special precautions, and more on MedlinePlus
decitabinemedlineplusdruginformation
https://www.inqovi.com/
INQOVI® (decitabine and cedazuridine) | AML and MDS Treatment
INQOVI is an oral prescription medicine used to treat acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), including chronic myelomonocytic...
decitabineamlmdstreatment
https://register.taihooncology.com/
Register for Updates | INQOVI® (decitabine and cedazuridine) 35 mg/100 mg tablets For HCPs | Taiho...
To receive updates about INQOVI and/or Taiho Oncology products and services please complete the form on this page.
register for updates